Platinum open access journal
pISSN 2466-0493 eISSN 2466-054X
Indexed in MEDLINE, SCIE, Scopus, DOAJ and more
    Korean J Urol. 2006 Oct;47(10):1074-1078. Korean.
    Published online Oct 31, 2006.
    https://doi.org/10.4111/kju.2006.47.10.1074
    Copyright © 2006 The Korean Urological Association
    Original Article

    The Factors that Influence the Clinical Outcomes after Trial without Catheter for Acute Urinary Retention due to Benign Prostatic Hyperplasia: a Multicenter Trial

    Su Hwan Park, Tae Gyun Kwon,1 Duk Yoon Kim,2 Chul Hee Park,3 Jun Hyoung Seo,4 Ju Hwan Lee,5 Hee Chang Jung,6 and Young Jin Seo
      • Department of Urology, College of Medicine, Dongguk University, Korea.
      • 1Department of Urology, Kyungpook National University College of Medicine, Korea.
      • 2Department of Urology, Catholic University of Daegu College of Medicine, Korea.
      • 3Department of Urology, Keimyung University College of Medicine, Korea.
      • 4Department of Urology, Kumi CHA Medical Center, College of Medicine, Pochon Cha University, Korea.
      • 5Department of Urology, Daegu Fatima Hospital, Korea.
      • 6Department of Urology, College of Medicine, Yeungnam University, Korea.
    • Corresponding author (Email: seoyjin@korea.com )
    Received March 30, 2006; Accepted August 13, 2006.

    Abstract

    Purpose

    Benign prostatic hyperplasia (BPH) is a common problem that's experienced by aging men, and it can lead to serious outcomes, including acute urinary retention (AUR). We studied the factors that influence the clinical outcomes after trial without catheter (TWOC) for AUR due to BPH.

    Materials and Methods

    The medical records of all 455 BPH patients who visited the emergency room for the first time with AUR from March 2001 through February 2005 were retrospectively reviewed. The patients were divided into two groups: the success group (group I) or failure group (group II) that underwent trial without catheter. The patient's characteristics were compared between the two groups using logistic regression analysis and the chi-square test.

    Results

    From the 292 cases of group I and the 163 cases of group II, the multivariate analysis revealed statistically significant differences in the retention volume (p<0.01), the prostate volume (p<0.01) and the previous use of α-blockers before AUR (p<0.01).

    Conclusions

    The prostate volume, retention volume and previous use of α-blockers before AUR were thought to influence the clinical outcomes of TWOC for the BPH patients with AUR, and these factors should be considered in future treatment planning.

    Keywords
    Benign prostatic hyperplasia; Urinary retention; Urinary catheterization

    Figures

    Fig. 1
    Success rate of trial without catheter after acute urinary retention according to the retention urine volume, the prostate size and the previous use of α-blockers (p<0.01).

    Tables

    Table 1
    Clinical parameters for trial without catheter (TWOC)

    Table 2
    Multivariate analysis using the logistic regression model

    References

      1. Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998;51:595–600.
      1. Lepor H. The pathophysiology of lower urinary tract symptoms in the ageing male population. Br J Urol 1998;81 Suppl 1:29–33.
      1. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243–247.
      1. Murray K, Massey A, Feneley RC. Acute urinary retention-a urodynamic assessment. Br J Urol 1984;56:468–473.
      1. Pickard R, Emberton M, Neal DE. National Prostatectomy Audit Group. The management of men with acute urinary retention. Br J Urol 1998;81:712–720.
      1. McNeill SA. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Eur Urol 2004;45:325–332.
      1. McNeill SA, Hargreave TB. Members of the Alfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol 2004;171:2316–2320.
      1. Annemans L, Cleemput I, Lamotte M, McNeill A, Hargreave T. The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis. BJU Int 2005;96:566–571.
      1. Manikandan R, Srirangam SJ, O'Reilly PH, Collins GN. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey. BJU Int 2004;93:84–88.
      1. Taube M, Gajraj H. Trial without catheter following acute retention of urine. Br J Urol 1989;63:180–182.
      1. Kumar V, Marr C, Bhuvangiri A, Irwin P. A prospective study of conservatively managed acute urinary retention: prostate size matters. BJU Int 2000;86:816–819.
      1. Djavan B, Shariat S, Omar M, Roehrborn CG, Marberger M. Does prolonged catheter drainage improve the chance of recovering voluntary voiding after acute urinary retention (AUR). Eur Urol 1998;33 Suppl 1:110.
        abstract 437.
      1. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997;158:481–487.
      1. Hartung R. Do alpha-blocker prevent the occurrence of acute urinary retnetion? Eur Urol 2001;39 Suppl 6:13–18.
      1. McNeill AS, Rizvi S, Byrne DJ. Prostate size influences the outcome after presenting with acute urinary retention. BJU Int 2004;94:559–562.
      1. Cockett AT, Khoury S, Aso Y. Proceedings of the 3rd International Consultation on benign prostatic hyperplasia; Channel Island: Scientific Communications International Ltd; 1995. pp. 1-651.
      1. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387–2398.
      1. Shim JH, Sohng IH, Jee KN, Kim HJ. Follow-up treatment of benign prostatic hyperplasia with acute urinary retention. Korean J Urol 2006;47:20–25.
      1. Martorana G, Giberti C, Di Silverio F, von Heland M, Rigatti P, Colombo R, et al. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia. Eur Urol 1997;32:47–53.
    Cited by
    Crossref 2
    Google Scholar 
    Scopus 1
    MeSH Terms
    Aging
    Catheters*
    Emergency Service, Hospital
    Humans
    Logistic Models
    Male
    Medical Records
    Multivariate Analysis
    Prostate
    Prostatic Hyperplasia*
    Retrospective Studies
    Urinary Catheterization
    Urinary Retention*
    Metrics
    Share
    Figures
    slide

    1 / 1

    Tables
    slide
    slide

    1 / 2

    PERMALINK